REFILE-Astra-Sanofi's RSV therapy 'highly effective' against infant hospitalizations, CDC study shows

In this article:

(Corrects typo in CDC agency's name in paragraph 1)

March 7 (Reuters) - AstraZeneca and Sanofi's antibody therapy was 90% effective in protecting infants from hospitalizations associated with respiratory syncytial virus (RSV), a study by the U.S. Centers for Disease Control and Prevention showed on Thursday. (Reporting by Sriparna Roy in Bengaluru; Editing by Shounak Dasgupta)

Advertisement